453-09-8

Basic information

• Product Name: Brn 1732049
• Synonyms: 1,3-Propanediol, 2-fluoro-;2-Deoxy-2-fluoroglycerol;2-Fluoro-1,3-propanediol;Brn 1732049;2-fluoropropane-1,3-diol
• CAS NO: 453-09-8
• Molecular Formula: C₃H₇FO₂
• Molecular Weight: 94.0848832
• Mol File: 453-09-8.mol

Chemical Properties

• Boiling Point: 223.3°Cat760mmHg
• Flash Point: 88.9°C
• Appearance: /
• Density: 1.192g/cm³
• CAS DataBase Reference: Brn 1732049(CAS DataBase Reference)
• NIST Chemistry Reference: Brn 1732049(453-09-8)
• EPA Substance Registry System: Brn 1732049(453-09-8)

Safety Data

• Hazardous Substances Data: 453-09-8(Hazardous Substances Data)

Upstream product

• 1993-92-6 2-fluoro-3-hydroxypropionic acid ethyl ester 
• 685-88-1 fluoromalonic acid diethyl ester 
• 344-14-9 dimethyl 2-fluoromalonate 
• 32804-09-4 3-acetoxy-2-fluoro-propan-1-ol 
• 33573-99-8 2-fluoro-1,3-bis-trityloxy-propane 

Downstream Products

• 433-07-8 2-fluoropropane-1,3-diyl bis(4-methylbenzenesulfonate) 
• 900809-19-0 3-{[tert-butyl(diphenyl)silyl]oxy}-2-fluoropropan-1-ol 

Relevant articles and documents

Synthesis and evaluation of N-(4-benzylphenyl)piperazines as VGF inducers

A series of compounds was discovered that induce the production of VGF mRNA in SH-SY5Y cells and exhibit cytoprotection under tunicamycin induced endoplasmic reticulum (ER) stress. The aminophenol ring and linker chain of the template SUN N8075 (1) was modified to yield compounds with higher efficacy and lower propensity for adverse effects.

NMDA RECEPTOR MODULATORS AND USES THEREOF

Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.

6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS

The present invention is directed to PDE4B inhibitors of Formula I: (I) or a pharmaceutically acceptable salt thereof, wherein the substituents R1, R2, R 3, and R 4are as defined herein. The invention is also di

METHOD FOR PRODUCING -FLUOROALCOHOL

A production method of a β-fluoroalcohol includes performing a reaction of an α-fluoroester with hydrogen gas (H2) in the presence of a specific ruthenium complex (i.e. a ruthenium complex of the general formula [2], preferably a ruthenium complex of the general formula [4]). This production method can employ a suitable hydrogen pressure of 1 MPa or less by the use of such a specific ruthenium complex and does not require a high-pressure gas production facility when put in industrial practice. In addition, this production method can remarkably reduce the amount of catalyst used therein (to e.g. a substrate/catalyst ratio of 20,000) in comparison to the substrate/catalyst ratio conventional reduction of α-fluoroalcohol. It is possible by these reduction in hydrogen pressure and catalyst amount to largely reduce the production cost of the β-fluoroalcohol.

INHIBITORS OF AKT ACTIVITY

Invented are novel 1 H-imidazo[4,5-c]pyridin-2-yl compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.